Sort   by:  
 Page size 
UnknownPacBio Amplicon Sequencing Method To Measure Pilin Antigenic Variation Frequencies of Neisseria gonorrhoeae.
Not available
S-EPMC6796969 | biostudies-literature
UnknownDNase H Activity of Neisseria meningitidis Cas9.
Not available
S-EPMC4609032 | biostudies-literature
Transcriptomicsheat shock SUMO-2 RNA-seq
RNA-seq analysis of poly-A RNA from untreated U2OS cells, and from U2OS cells exposed to heat stress (43 C) for 4 hours
ORGANISM(S): Homo sapiens 
2015-07-15 | E-MTAB-2349 | biostudies-arrayexpress
UnknownNatural compounds target the M23B zinc metallopeptidase Mpg to modulate <i>Neisseria gonorrhoeae</i> Type IV pilus expression.
Not available
S-EPMC11980366 | biostudies-literature
UnknownThe classical pathway triggers pathogenic complement activation in membranous nephropathy.
Not available
S-EPMC9884226 | biostudies-literature
UnknownEffects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867 | biostudies-literature
UnknownLong-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7616743 | biostudies-literature
UnknownEffects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591 | biostudies-literature
UnknownImpact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
Not available
S-EPMC7618536 | biostudies-literature
UnknownFrailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031 | biostudies-literature
Sort   by:  
 Page size